Your browser doesn't support javascript.
loading
Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment.
Ungerleider, Nathan A; Rao, Sonia G; Shahbandi, Ashkan; Yee, Douglas; Niu, Tianhua; Frey, Wesley D; Jackson, James G.
Afiliación
  • Ungerleider NA; Department of Pathology, Tulane School of Medicine, New Orleans, LA, USA.
  • Rao SG; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, 1430 Tulane Avenue, mail code 8543, New Orleans, LA, 70112, USA.
  • Shahbandi A; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, 1430 Tulane Avenue, mail code 8543, New Orleans, LA, 70112, USA.
  • Yee D; Division of Hematology, Oncology and Transplantation, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  • Niu T; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, 1430 Tulane Avenue, mail code 8543, New Orleans, LA, 70112, USA.
  • Frey WD; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, 1430 Tulane Avenue, mail code 8543, New Orleans, LA, 70112, USA.
  • Jackson JG; Department of Biochemistry and Molecular Biology, Tulane School of Medicine, 1430 Tulane Avenue, mail code 8543, New Orleans, LA, 70112, USA. jjacks8@tulane.edu.
Breast Cancer Res ; 20(1): 115, 2018 10 01.
Article en En | MEDLINE | ID: mdl-30285883
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína p53 Supresora de Tumor / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína p53 Supresora de Tumor / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos